This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dmitriev, I.
Right arrow Articles by Curiel, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dmitriev, I.
Right arrow Articles by Curiel, D. T.

 Previous Article  |  Next Article 

Journal of Virology, August 2000, p. 6875-6884, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Ectodomain of Coxsackievirus and Adenovirus Receptor Genetically Fused to Epidermal Growth Factor Mediates Adenovirus Targeting to Epidermal Growth Factor Receptor-Positive Cells

Igor Dmitriev,1 Elena Kashentseva,1 Buck E. Rogers,2 Victor Krasnykh,1 and David T. Curiel1,*

Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center,1 and Department of Radiation Oncology,2 University of Alabama at Birmingham, Birmingham, Alabama 35294-3300

Received 2 February 2000/Accepted 28 April 2000

Human adenovirus (Ad) is extensively used for a variety of gene therapy applications. However, the utility of Ad vectors is limited due to the low efficiency of Ad-mediated gene transfer to target cells expressing marginal levels of the Ad fiber receptor. Therefore, the present generation of Ad vectors could potentially be improved by modification of Ad tropism to target the virus to specific organs and tissues. The fact that coxsackievirus and adenovirus receptor (CAR) does not play any role in virus internalization, but functions merely as the virus attachment site, suggests that the extracellular part of CAR might be utilized to block the receptor recognition site on the Ad fiber knob domain. We proposed to design bispecific fusion proteins formed by a recombinant soluble form of truncated CAR (sCAR) and a targeting ligand. In this study, we derived sCAR genetically fused with human epidermal growth factor (EGF) and investigated its ability to target Ad infection to the EGF receptor (EGFR) overexpressed on cancer cell lines. We have demonstrated that sCAR-EGF protein is capable of binding to Ad virions and directing them to EGFR, thereby achieving targeted delivery of reporter gene. These results show that sCAR-EGF protein possesses the ability to effectively retarget Ad via a non-CAR pathway, with enhancement of gene transfer efficiency.

* Corresponding author. Mailing address: Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, 1824 6th Ave., South, Room WTI 620, Birmingham, AL 35294-3300. Phone: (205) 934-8627. Fax: (205) 975-7476. E-mail: David.Curiel{at}ccc.uab.edu.

Journal of Virology, August 2000, p. 6875-6884, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Li, H.-J., Everts, M., Pereboeva, L., Komarova, S., Idan, A., Curiel, D. T., Herschman, H. R. (2007). Adenovirus Tumor Targeting and Hepatic Untargeting by a Coxsackie/Adenovirus Receptor Ectodomain Anti-Carcinoembryonic Antigen Bispecific Adapter. Cancer Res. 67: 5354-5361 [Abstract] [Full Text]  
  • Tanaka, T., Huang, J., Hirai, S., Kuroki, M., Kuroki, M., Watanabe, N., Tomihara, K., Kato, K., Hamada, H. (2006). Carcinoembryonic Antigen-Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus Vectors.. Clin. Cancer Res. 12: 3803-3813 [Abstract] [Full Text]  
  • Verheije, M. H., Wurdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., Rottier, P. J. M. (2006). Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter. J. Virol. 80: 1250-1260 [Abstract] [Full Text]  
  • Kuhnel, F., Schulte, B., Wirth, T., Woller, N., Schafers, S., Zender, L., Manns, M., Kubicka, S. (2004). Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors. J. Virol. 78: 13743-13754 [Abstract] [Full Text]  
  • Ponnazhagan, S., Mahendra, G., Kumar, S., Shaw, D. R., Stockard, C. R., Grizzle, W. E., Meleth, S. (2004). Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor. Cancer Res. 64: 1781-1787 [Abstract] [Full Text]  
  • Korokhov, N., Mikheeva, G., Krendelshchikov, A., Belousova, N., Simonenko, V., Krendelshchikova, V., Pereboev, A., Kotov, A., Kotova, O., Triozzi, P. L., Aldrich, W. A., Douglas, J. T., Lo, K.-M., Banerjee, P. T., Gillies, S. D., Curiel, D. T., Krasnykh, V. (2003). Targeting of Adenovirus via Genetic Modification of the Viral Capsid Combined with a Protein Bridge. J. Virol. 77: 12931-12940 [Abstract] [Full Text]  
  • Rux, J. J., Kuser, P. R., Burnett, R. M. (2003). Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods. J. Virol. 77: 9553-9566 [Abstract] [Full Text]  
  • Volpers, C., Thirion, C., Biermann, V., Hussmann, S., Kewes, H., Dunant, P., von der Mark, H., Herrmann, A., Kochanek, S., Lochmuller, H. (2003). Antibody-Mediated Targeting of an Adenovirus Vector Modified To Contain a Synthetic Immunoglobulin G-Binding Domain in the Capsid. J. Virol. 77: 2093-2104 [Abstract] [Full Text]  
  • Ponnazhagan, S., Mahendra, G., Kumar, S., Thompson, J. A., Castillas, M. Jr. (2002). Conjugate-Based Targeting of Recombinant Adeno-Associated Virus Type 2 Vectors by Using Avidin-Linked Ligands. J. Virol. 76: 12900-12907 [Abstract] [Full Text]  
  • van Beusechem, V. W., Grill, J., Mastenbroek, D. C. J., Wickham, T. J., Roelvink, P. W., Haisma, H. J., Lamfers, M. L. M., Dirven, C. M. F., Pinedo, H. M., Gerritsen, W. R. (2002). Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished. J. Virol. 76: 2753-2762 [Abstract] [Full Text]  
  • Kim, J., Smith, T., Idamakanti, N., Mulgrew, K., Kaloss, M., Kylefjord, H., Ryan, P. C., Kaleko, M., Stevenson, S. C. (2002). Targeting Adenoviral Vectors by Using the Extracellular Domain of the Coxsackie-Adenovirus Receptor: Improved Potency via Trimerization. J. Virol. 76: 1892-1903 [Abstract] [Full Text]  
  • Seki, T., Dmitriev, I., Kashentseva, E., Takayama, K., Rots, M., Suzuki, K., Curiel, D. T. (2002). Artificial Extension of the Adenovirus Fiber Shaft Inhibits Infectivity in Coxsackievirus and Adenovirus Receptor-Positive Cell Lines. J. Virol. 76: 1100-1108 [Abstract] [Full Text]  
  • Vorburger, S. A., Hunt, K. K. (2002). Adenoviral Gene Therapy. The Oncologist 7: 46-59 [Abstract] [Full Text]  
  • Kashentseva, E. A., Seki, T., Curiel, D. T., Dmitriev, I. P. (2002). Adenovirus Targeting to c-erbB-2 Oncoprotein by Single-Chain Antibody Fused to Trimeric Form of Adenovirus Receptor Ectodomain. Cancer Res. 62: 609-616 [Abstract] [Full Text]  
  • Kanerva, A., Mikheeva, G. V., Krasnykh, V., Coolidge, C. J., Lam, J. T., Mahasreshti, P. J., Barker, S. D., Straughn, M., Barnes, M. N., Alvarez, R. D., Hemminki, A., Curiel, D. T. (2002). Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells. Clin. Cancer Res. 8: 275-280 [Abstract] [Full Text]  
  • Vos, A., Neubert, A., Pommerening, E., Muller, T., Dohner, L., Neubert, L., Hughes, K. (2001). Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J. Gen. Virol. 82: 2191-2197 [Abstract] [Full Text]  
  • Hemminki, A., Dmitriev, I., Liu, B., Desmond, R. A., Alemany, R., Curiel, D. T. (2001). Targeting Oncolytic Adenoviral Agents to the Epidermal Growth Factor Pathway with a Secretory Fusion Molecule. Cancer Res. 61: 6377-6381 [Abstract] [Full Text]  
  • Pereboev, A., Pereboeva, L., Curiel, D. T. (2001). Phage Display of Adenovirus Type 5 Fiber Knob as a Tool for Specific Ligand Selection and Validation. J. Virol. 75: 7107-7113 [Abstract] [Full Text]  
  • Krasnykh, V., Belousova, N., Korokhov, N., Mikheeva, G., Curiel, D. T. (2001). Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 Fibritin. J. Virol. 75: 4176-4183 [Abstract] [Full Text]  
  • Lam, P. Y.P., Breakefield, X. O. (2001). Potential of gene therapy for brain tumors. Hum Mol Genet 10: 777-787 [Abstract] [Full Text]  
  • Jakubczak, J. L., Rollence, M. L., Stewart, D. A., Jafari, J. D., Von Seggern, D. J., Nemerow, G. R., Stevenson, S. C., Hallenbeck, P. L. (2001). Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells. J. Virol. 75: 2972-2981 [Abstract] [Full Text]  
  • Snitkovsky, S., Niederman, T. M. J., Mulligan, R. C., Young, J. A. T. (2001). Targeting Avian Leukosis Virus Subgroup A Vectors by Using a TVA-VEGF Bridge Protein. J. Virol. 75: 1571-1575 [Abstract] [Full Text]  
  • Ebbinghaus, C., Al-Jaibaji, A., Operschall, E., Schöffel, A., Peter, I., Greber, U. F., Hemmi, S. (2001). Functional and Selective Targeting of Adenovirus to High-Affinity Fc{gamma} Receptor I-Positive Cells by Using a Bispecific Hybrid Adapter. J. Virol. 75: 480-489 [Abstract] [Full Text]  
  • Krasnykh, V., Dmitriev, I., Navarro, J.-G., Belousova, N., Kashentseva, E., Xiang, J., Douglas, J. T., Curiel, D. T. (2000). Advanced Generation Adenoviral Vectors Possess Augmented Gene Transfer Efficiency Based upon Coxsackie Adenovirus Receptor-independent Cellular Entry Capacity. Cancer Res. 60: 6784-6787 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»